Walleye Capital LLC Viatris Inc Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $1.55 Million - $1.82 Million	150,000 Added 185.41%	230,900 $2.68 Million
Q2 2024 Aug 14, 2024	BUY	$10.05 - $12.02 $416,070 - $497,628	41,400 Added 104.81%	80,900 $859,000
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $250,194 - $300,366	22,200 Added 128.32%	39,500 $471,000
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $151,721 - $187,705	17,300 New	17,300 $187,000
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $225,500 - $257,249	-25,000 Reduced 94.7%	1,400 $13,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $242,879 - $323,664	26,400 New	26,400 $253,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.